Skip to content

Study · Not a test of the peptide alone · 2005

3 results

Autoantibodies against neuropeptides are associated with psychological traits in eating disorders.

Fetissov SO, Harro J, Jaanisk M, Järv A, Podar I, Allik J, Nilsson I, Sakthivel P, Lefvert AK, Hökfelt T

Proceedings of the National Academy of Sciences of the United States of America29 Sept 2005Cited by 115 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01HumanNot a test of Oxytocin aloneObservational studyOther

    In patients with anorexia nervosa or bulimia nervosa and in controls, autoantibodies that react with oxytocin were present.

    In plain wordsIn people with eating disorders and in controls, the blood held antibodies that react with the body's own oxytocin.

    Peptide
    Oxytocin
    Outcome
    Not applicableAutoantibodies reacting with oxytocin
    Study

    n: not reported in source

    Comparator
    Controls
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    In addition to previously identified neuropeptide autoAbs, the current study revealed the presence of autoAbs reacting with oxytocin (OT) or vasopressin (VP) in both patients and controls.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  2. 02HumanNot a test of Oxytocin aloneObservational studyOther

    In anorexia nervosa patients, serum IgM autoantibodies against oxytocin were higher than in bulimia nervosa patients and controls.

    In plain wordsIn people with anorexia nervosa, blood antibodies against oxytocin were higher than in people with bulimia nervosa and in controls.

    Peptide
    Oxytocin
    Outcome
    IncreaseSerum IgM autoantibodies against oxytocin
    Study

    n: not reported in source

    Comparator
    Bulimia nervosa patients and controls
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Analysis of serum levels of identified autoAbs showed an increase of IgM autoAbs against alpha-MSH, OT, and VP as well as of IgG autoAbs against VP in AN patients when compared with BN patients and controls.
    1 context sentence
    Summary · context
    In this work, we studied the relevance of such autoAbs to AN and BN.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

  3. 03HumanNot a test of Oxytocin aloneObservational studyOther

    In anorexia nervosa and bulimia nervosa patients, oxytocin autoantibody levels had only a few altered correlations with Eating Disorder Inventory-2 subscale dimensions.

    In plain wordsIn people with eating disorders, oxytocin antibody levels were linked to only a few eating disorder trait scores.

    Peptide
    Oxytocin
    Outcome
    MixedCorrelation of oxytocin autoantibodies with EDI-2 subscales
    Study

    n: not reported in source

    Outcome group
    Anxiety and mood · Mental health and mood

    Source sentences

    Summary
    In contrast, levels of autoAbs reacting with adrenocorticotropic hormone, OT, or VP had only few altered correlations with the Eating Disorder Inventory-2 subscale dimensions in AN and BN patients.
    1 context sentence
    Summary · context
    In this work, we studied the relevance of such autoAbs to AN and BN.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:53 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.